D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
about
D-Cycloserine in Neuropsychiatric Diseases: A Systematic ReviewTowards medication-enhancement of cognitive interventions in schizophreniaFuture clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophreniad-Cycloserine augmentation of cognitive remediation in schizophrenia.D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia.Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.A novel treatment for tinnitus and tinnitus-related cognitive difficulties using computer-based cognitive training and D-cycloserineStructural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.Word use in first-person accounts of schizophrenia.Augmenting NMDA receptor signaling boosts experience-dependent neuroplasticity in the adult human brainD-serine as a gliotransmitter and its roles in brain development and disease.Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia.Failure of neural responses to safety cues in schizophreniaThe 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders.D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.Improving Current Treatments for Schizophrenia.Neuropsychiatric Effects of Antimicrobial Agents.Beyond antipsychotics: pharmacologically-augmented cognitive therapies (PACTs) for schizophrenia.The doxastic shear pin: delusions as errors of learning and memory.Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.NMDA Receptors in the Central Nervous System.Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.Natural Medicines for Psychotic Disorders: A Systematic Review.
P2860
Q26781321-B31B5A75-CAB4-4A52-9DAD-35D36CCC8F84Q26860777-BE5C0EE2-9F9A-4977-82D8-F09069A6906AQ27014120-DC0F4D9C-EDA4-42E8-926F-78D54D3B969DQ30404599-A3151C55-6D68-490D-94CC-6F1270D15801Q30450078-29748C0C-CCFB-4DA5-BBBD-A9B27A7E7D24Q30454958-DCB1C7B4-BB16-4EF8-A761-A371DE25CEF8Q33708292-4C476A8D-C546-4742-AAAD-7419DB93B71FQ33912531-4FB599E9-0301-4631-AC73-2E84B1C0E94FQ34360057-F1196B4C-1830-4017-8D90-360B670F5859Q34817575-FF12F833-A064-40CE-8013-DA9E82CAE305Q36394299-674CCC43-FB07-4606-98D5-19F119926071Q36785486-2307434A-5531-4876-856A-26B76A5C3AD6Q36930839-E3780142-9FCB-408D-BC2E-A69276FBB83CQ37156104-DE0E72BD-FF7B-4660-A90C-DC68049037C1Q37425054-5DC0E0C3-999C-4846-B9C3-664F245F806AQ38123594-517D976D-41CE-430B-A1FB-FC4080822CBBQ38750121-3159AF23-E845-4073-A59C-9AE9EE4DA926Q38955513-B9141EAD-3775-4C54-880B-044139F34640Q39135986-3F6AF6AD-975D-4422-8532-E4DA539C115BQ39794390-FFA806DB-E5D0-4AF9-A8E1-C9843363F37DQ39996305-2516F244-9A49-4A47-B20E-65345755D999Q46116077-DE356BAD-5A88-431B-87B3-50E3928254EBQ48029905-37648FE2-B35F-48D7-940D-99C67AF8AEA1Q48408095-1C5C34C0-78B6-40FB-A953-D7F12A5323E3Q49363880-70B58A49-3D3E-4A1A-8970-D762C5F70FC1
P2860
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@ast
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@en
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@nl
type
label
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@ast
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@en
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@nl
prefLabel
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@ast
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@en
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@nl
P2093
P2860
P1476
D-cycloserine facilitation of ...... or delusions in schizophrenia.
@en
P2093
Corinne Cather
Eric A Macklin
Jennifer D Gottlieb
Meghan Shanahan
Timothy Creedon
P2860
P356
10.1016/J.SCHRES.2011.05.029
P407
P577
2011-06-30T00:00:00Z